FDA Inspection 1089676 — Penn State Health Holy Spirit Medical Center
The FDA completed an inspection of Penn State Health Holy Spirit Medical Center on Apr 18, 2019 in Camp Hill, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 18, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Camp Hill, PA (United States)